Hepcare Europe - bridging the gap in the treatment of hepatitis C: study protocol
2018
ABSTRACTBackground: Hepatitis C (HCV) infection is highly prevalent among people who inject drugs (PWID). Many PWID are unaware of their infection and few have received HCV treatment. Recent developments in treatment offer cure rates >90%. However, the potential of these treatments will only be realised if HCV identification among PWID with linkage to treatment is optimised. This paper describes the Hepcare Europe project, a collaboration between five institutions across four member states (Ireland, UK, Spain, Romania), to develop, implement and evaluate interventions to improve the identification, evaluation and treatment of HCV among PWID.Methods: A service innovation project and a mixed-methods, pre-post intervention study, Hepcare will design and deliver interventions in Dublin, London, Seville and Bucharest to enhance PWID engagement and retention in the cascade of HCV care.Results: The feasibility, acceptability, potential efficacy and cost-effectiveness of these interventions to improve care proces...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
50
References
17
Citations
NaN
KQI